Intoxication Anosognosia: The Spellbinding Effect of Psychiatric Drugs

Breggin, Peter R.
November 2006
Ethical Human Psychology & Psychiatry;Fall2006, Vol. 8 Issue 3, p201
Academic Journal
Why do so many individuals persist in taking psychoactive substances, including psychiatric drugs, after adverse mental and behavioral effects have become severe and even disabling? The author has previously proposed the brain-disabling principle of psychiatric treatment that all somatic psychiatric treatments impair the function of the brain and mind. Intoxication anosognosia (medication spellbinding) is an expression of this drug-induced mental disability. Intoxication anosognosia causes the victim to underestimate the degree of drug-induced mental impairment, to deny the harmful role that the drug plays in the person's altered state, and in many cases compel the individual to mistakenly believe that he or she is functioning better. In the extreme, the individual displays out-of-character compulsively destructive behaviors, including violence toward self and others.


Related Articles

  • Comments from the Trenches: Proposed Changes to the DSM-V Classification of Pathological Gambling. Mitzner, George; Whelan, James; Meyers, Andrew // Journal of Gambling Studies;Sep2011, Vol. 27 Issue 3, p517 

    The proposed DSM-V changes related to the pathological gambling diagnosis hold far-reaching implications, yet these modifications have been met with little public attention. This letter addresses the three changes proposed including the diagnosis' reclassification alongside other addictive...

  • Tramadol intoxication: a review of 114 cases. Shadnia, S.; Soltaninejad, K.; Heydari, K.; Sasanian, G.; Abdollahi, M. // Human & Experimental Toxicology;Mar2008, Vol. 27 Issue 3, p201 

    Tramadol as a centrally acting analgesic is extensively used in the management of moderate to severe pain. It slightly affects opioid receptors and inhibits the reuptake of norepinephrin and serotonin in the CNS. There are reports about toxicity and abuse of tramadol. The objective of the...

  • Assessment of Alcohol Use Disorders Among Court-Mandated DWI Offenders. Stasiewicz, Paul R.; Nochajski, Thomas H.; Homish, D. Lynn // Journal of Addictions & Offender Counseling;Apr2007, Vol. 27 Issue 2, p102 

    Convicted DWI offenders (N = 549) were assessed for alcohol use disorders. Repeat offenders had twice the rate of both lifetime and current alcohol use disorders compared with 1st-time offenders. Guidelines for determining alcohol problems in DWI offenders are recommended.

  • The neuroscience of addiction. Volkow, Nora; Ting-Kai Li // Nature Neuroscience;Nov2005, Vol. 8 Issue 11, p1429 

    Focuses on issues and topics related the neuroscience of addiction. Reasons why some people become addicted and others do not; Identification of behaviors among adolescents that predispose them to addiction; Risks for people with mental disabilities towards abusing drugs and alcohol.

  • Blinded by Biochemistry. Peele, Stanton // Psychology Today;Sep/Oct2010, Vol. 43 Issue 5, p52 

    The article focuses on the "Diagnostic and Statistical Manual (DSM-5)," which is set to be published by the American Psychiatric Association (APA) in May 2013. A draft was issued in February 2010. DSM-IV is the current version of the DSM, which used the term dependence as reference to addiction....

  • Monoamine Oxidase Inhibitors and Neuroprotective Mechanisms. Baker, Glen B.; Matveychuk, Dmitriy; MacKenzie, Erin M.; Dursun, Serdar M.; Mousseau, Darrell D. // Klinik Psikofarmakoloji Bulteni;Dec2012, Vol. 22 Issue 4, p293 

    There has been a resurgence of interest in recent years in monoamine oxidase inhibitors, primarily because of the demonstrated neuroprotective and/or neurorescue properties of several of these drugs in a variety of toxic situations in vivo and in vitro. The consequence has been an increased...

  • Research on the Phenomenon and Treatment of Addiction: A Multi-Disciplinary Perspective. Strahilevitz, Michal Ann // Advances in Consumer Research;1994, Vol. 21 Issue 1, p233 

    Presents a variety of perspectives on the topic of addiction. Economic aspects of addiction; Differences and similarities in the experiences and recovery processes of various addictions; Treatment of alcohol and drug abuse problem from a social systems perspectives.

  • Undiagnosed Drug Misuse Among Admissions to Psychiatric Day Treatment and Prediction of Early Exit. Magura, Stephen; Spybrook, Jessaca; Rosenblum, Andrew; Chunki Fong; Villano, Cherie; Vogel, Howard S.; Betzler, Thomas // Open Addiction Journal;2010, Vol. 3, p102 

    A challenge for psychiatric treatment programs is to accurately identify individuals with drug misuse problems at admission to treatment. Consecutive new admissions to an urban continuing day treatment program (n=229) during 2003-2005 were recruited and their treatment status was determined...

  • An early evangelist for treating opioid addiction. Muchmore, Shannon // Modern Healthcare;1/18/2016, Vol. 46 Issue 3, p0014 

    The article announces Boston Medical Center program director Colleen Labelle as the recipient of the Lillian Carter Exemplary Acts in Nursing Award for her pioneering efforts in opioid addiction treatment through the Opioid Treatment with Buprenorphine program.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics